TG Therapeutics

FDA grants IND clearance for TG Therapeutics’ trial of multiple sclerosis treatment
Clinical Trials Arena
Mon, 08/12/24 - 11:25 am
Precision Biosciences
TG Therapeutics
FDA
azer-cel
progressive MS
MS
clinical trials
TG shares tumble following licensing deal for MS drug
BioPharma Dive
Tue, 08/1/23 - 10:24 pm
TG Therapeutics
MS
multiple sclerosis
Briumvi
CHMP gives thumbs-up for Wegovy use in adolescents, along with nine new drug recommendations
Endpoints
Sun, 04/2/23 - 04:17 pm
EMA
Europe
CHMP
Wegovy
Novo Nordisk
Bimervax
TG Therapeutics
Eli Lilly
Bristol Myers Squibb
Novartis
AstraZeneca
FDA approves drugs from Gilead, Roche, TG Therapeutics to close 2022
BioPharma Dive
Wed, 01/4/23 - 10:11 am
FDA
drug approvals
HIV
lymphoma
multiple sclerosis
Gilead Sciences
Roche
TG Therapeutics
Go or no go? Mirati heads to the FDA
EP Vantage
Wed, 11/30/22 - 10:34 am
FDA
Mirati Therapeutics
Gilead Sciences
Coherus Biosciences
Roche
Biogen
TG Therapeutics
Ipsen
Novartis
BeiGene
Cytokinetics
ICER on MS drugs: TG's ublituximab not cost effective at the same price as Roche's ocrelizimab
Endpoints
Tue, 10/18/22 - 10:36 am
ICER
MS
multiple sclerosis
drug pricing
ublituximab
TG Therapeutics
Brace for an end-of-year boost to drug approvals
EP Vantage
Fri, 09/2/22 - 12:14 pm
FDA
drug approvals
Alnylam Pharmaceuticals
Apellis Pharmaceuticals
Bristol Myers Squibb
Eli Lilly
Gilead Sciences
Mirati Therapeutics
Moderna Therapeutics
Provention Bio
Roche
TG Therapeutics
Travere Therapeutics
FDA withdraws cancer drug approval after finding possible higher death rates
RAPS.org
Wed, 06/1/22 - 07:39 pm
TG Therapeutics
clinical trials
Ukoniq
cancer
TG Therapeutics Backpedals on BLA for Lymphoma, Leukemia Treatment
BioSpace
Mon, 04/18/22 - 10:58 am
TG Therapeutics
ublituximab-umbralisib
chronic lymphocytic leukemia
small lymphocytic lymphoma
BMS, Novartis, Akebia and more face FDA approval decisions soon, with big sales on the line
Fierce Pharma
Thu, 03/3/22 - 10:33 am
FDA
drug approvals
FibroGen
AstraZeneca
daprodustat
Bristol Myers Squibb
Opdivo
Roche
tiragolumab
Merck
favezelima
bInnovent
Eli Lilly
Akeso Biopharma
Sino Biopharmaceutical
Novartis
Ukoniq
TG Therapeutics
GW Pharmaceuticals
Marinus Pharmaceuticals
TG slips out a nasty surprise for investors
EP Vantage
Mon, 01/31/22 - 10:40 am
TG Therapeutics
FDA
CLL
clinical hold
Samsung Biologics and TG Therapeutics expand blood cancer partnership
Biopharma Reporter
Tue, 04/27/21 - 10:53 am
TG Therapeutics
Samsung BioLogics
ublituximab
monoclonal antibodies
TG Therapeutics completes FDA filing for Roche challenger in CLL
Pharmaforum
Tue, 03/30/21 - 11:11 am
TG Therapeutics
FDA
antibodies
CLL
ublituximab-umbralisib
Watch out, Gilead: TG Therapeutics wins FDA nod for potentially safer Zydelig rivalrnings season continues to show COVID-19 uncertainty
Fierce Pharma
Mon, 02/8/21 - 10:38 pm
TG Therapeutics
FDA
Ukoniq
umbralisib
follicular lymphoma
marginal zone lymphoma
Gilead Sciences
Mark Your Calendar For February PDUFA Dates
Yahoo/Benzinga
Sun, 01/31/21 - 10:18 pm
FDA
Adamas Pharmaceuticals
Gocovri
Mallinckrodt
StrataGraft
Regeneron
evinacumab
Sanofi
Sarepta
TG Therapeutics
Go or no go? Oncology decisions ahead for the FDA
EP Vantage
Wed, 01/27/21 - 11:55 am
FDA
cancer
oncology
Bristol-Myers Squibb
TG Therapeutics
Mallinckrodt
Sanofi
Regeneron
Sarepta Therapeutics
GSK
Oncopeptide
10 Biopharma Stories to Look Forward to in 2021
BioSpace
Sun, 01/3/21 - 04:39 pm
pandemic
COVID-19
vaccines
Joe Biden
drug pricing
M&A
venture capital
JNJ
Biomarin
Bluebird Bio
TG Therapeutics
Biogen
AstraZeneca
TG Therapeutics set for upsized IPO to develop cancer combination drug
Pharmaforum
Tue, 12/15/20 - 10:33 am
TG Therapeutics
ASH2020
IPOs
CLL
TG adds a multiple sclerosis string to its bow
EP Vantage
Fri, 12/11/20 - 11:07 am
TG Therapeutics
hematology
ASH2020
ublituximab
MS
multiple sclerosis
FDA to decide on TG Therapeutics’ lymphoma drug early next year
Pharmaforum
Thu, 08/13/20 - 11:53 pm
TG Therapeutics
FDA
lymphoma
umbralisib
Bristol-Myers Squibb
Roche

Pages